AVIR

NASDAQStock

Atea Pharmaceuticals, Inc.

$6.09-0.01 (-0.16%)

52-Week Range

$2.55

$6.15

Key Stats

Market Cap

475.8M

P/E Ratio

—

Dividend Yield

—

Beta

0.26

Volume

367.8K

Avg Volume

697.3K

Performance

+40.88%

+93.65%

+100.66%

YTD

+75.29%

+98.05%

+67.12%

-91.26%

Price Chart

ETF Exposure

AVIR is held by 62 ETFs

ETF	Fund Name	Weight	Shares	Market Value	Fund AUM	Expense Ratio
ITDF	iShares LifePath Target Date 2050 ETF	0.00%	46	$280	$57.9M	0.11%
ITDG	iShares LifePath Target Date 2055 ETF	0.00%	38	$233	$42.1M	0.12%
ITDH	iShares LifePath Target Date 2060 ETF	0.00%	25	$154	$28.3M	0.12%
ITDI	iShares LifePath Target Date 2065 ETF	0.00%	19	$116	$21.0M	0.12%
ITDJ	iShares LifePath Target Date 2070 ETF	0.00%	9	$51	$9.3M	0.12%
VCNS.TO	Vanguard Conservative ETF Portfolio	0.00%	116	$669	$820.6M	0.25%
VEQT.TO	Vanguard All-Equity ETF Portfolio	0.00%	4,161	$24K	$12.17B	0.24%
VRIF.TO	Vanguard Retirement Income ETF Portfolio	0.00%	20	$115	$337.7M	0.32%
VTHR	Vanguard Russell 3000 ETF	0.00%	5,932	$25K	$5.50B	0.06%
VTI	Vanguard Total Stock Market ETF	0.00%	2,369,422	$10.0M	$2.10T	0.03%
VUN.TO	Vanguard U.S. Total Market Index ETF	0.00%	12,462	$72K	$15.33B	0.17%
VUS.TO	Vanguard U.S. Total Market Index ETF (CAD-hedged)	0.00%	1,074	$6K	$1.29B	0.17%

PreviousPage 2 of 2

About AVIR ETF Exposure

Atea Pharmaceuticals, Inc. (AVIR) is held by 62 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 475.8M, AVIR is a widely held institutional stock. The stock currently trades at $6.09. Investors can gain exposure to AVIR through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold AVIR, sorted by portfolio weight.